What is the initial treatment for gastritis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: August 12, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Initial Treatment for Gastritis

The preferred initial treatment for gastritis is a 14-day quadruple therapy regimen containing a proton pump inhibitor, bismuth subsalicylate, tetracycline, and metronidazole, which has an eradication rate of 85%. 1

Diagnosis Before Treatment

Before initiating treatment, proper diagnosis is essential:

  • Stop proton pump inhibitors (PPIs) for at least 2 weeks before testing to avoid false-negative results
  • Use either urea breath test (UBT) or monoclonal antibody-based stool antigen test for diagnosis (sensitivity 95%, specificity 90%)
  • If PPIs cannot be stopped, validated IgG serology can be performed as it's not affected by PPI use 1

Treatment Options

First-Line Treatment Regimens

  1. Bismuth quadruple therapy (preferred) - 14 days:

    • Proton pump inhibitor
    • Bismuth subsalicylate
    • Tetracycline
    • Metronidazole
    • Eradication rate: 85% 1
  2. Concomitant non-bismuth quadruple therapy - 14 days:

    • Proton pump inhibitor
    • Amoxicillin
    • Metronidazole
    • Clarithromycin
    • Eradication rate: 80% 1
  3. Standard triple therapy - 14 days (for areas with low clarithromycin resistance <20%):

    • Proton pump inhibitor
    • Clarithromycin
    • Amoxicillin
    • Eradication rate: 85% 1

Important Treatment Considerations

  • In areas with high clarithromycin resistance, bismuth-containing quadruple therapy is preferred 1
  • Concomitant antacids should be given as needed for pain relief 2
  • Follow-up testing should be performed at least 4 weeks after treatment completion to confirm bacterial eradication 1

Special Patient Populations

  • Patients over 45 years with severe symptoms or any patients with alarm symptoms (anemia, weight loss, dysphagia, palpable mass, malabsorption) should be referred for endoscopy before treatment 1
  • Younger patients (<45 years) without alarm symptoms can be managed in primary care with H. pylori testing and eradication 1
  • For gastric ulcers, proton pump inhibitor therapy should be continued until complete healing is achieved 1
  • For duodenal ulcers, proton pump inhibitor therapy should be continued until bacterial eradication is confirmed 1

Management of Treatment Failure

  • If first-line therapy fails, use a different regimen than the initial treatment 1
  • After two treatment failures, obtain antimicrobial susceptibility testing to guide further treatment 1
  • For treatment-experienced patients with persistent H. pylori infection, "optimized" bismuth quadruple therapy for 14 days is preferred 1

Common Side Effects and Management

  • Common side effects include diarrhea, skin rash, vomiting, nausea, metallic taste, and muscle/joint pains
  • Probiotics may help reduce side effects, though evidence is limited 1
  • Penicillin allergy testing should be considered in patients with a history of penicillin allergy but without anaphylaxis 1

Important Clinical Pitfalls

  1. Failing to stop PPIs before diagnostic testing, leading to false-negative results
  2. Using inadequate treatment duration (14 days is recommended for optimal eradication)
  3. Not confirming eradication after treatment completion
  4. Misdiagnosing chronic gastritis as the cause of long-standing upper abdominal complaints 3
  5. Not recognizing that PPIs alone are ineffective in eradicating H. pylori (eradication rate 0% at 6 months) 4

References

Guideline

Gastrointestinal Infection Management

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Gastritis--a misused term in clinical gastroenterology.

Scandinavian journal of gastroenterology. Supplement, 1988

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.